Duloxetine Pediatric Dosing
ورودیهای بالینی بیمار
حداقل ۲ — حداکثر ۱۵۰ • واحد: kg
حداقل ۷ — حداکثر ۱۷ • واحد: years
پارامترهای بالینی بیمار را در فرم روبرو وارد کنید و روی «محاسبه» کلیک نمایید تا نمره، طبقه خطر و اقدامات فوری نمایش داده شوند.
- calculated≥ 0
The Duloxetine Pediatric Dosing calculates calculating weight-based pediatric dosing and evaluating age-specific physiological parameters. Key inputs include weight kg. Scores guide titrating weight-adjusted medication dosing, monitoring developmental safety, and evaluating treatment response. This standardized assessment improves clinical decision safety and bedside patient management.
Clinical Guidelines & Evidence
Duloxetine dosing for pediatric generalized anxiety disorder.
Clinical Indication
The Duloxetine Pediatric Dosing is indicated for bedside clinical practice to support Duloxetine dosing for pediatric generalized anxiety disorder.. It assists healthcare providers in standardizing clinical assessment and therapeutic decision-making.
Target Population
Target population comprises Neonates, infants, children, and adolescents from birth up to 18 years of age. Clinical application is indicated across Pediatric emergency departments, pediatric inpatient wards, PICU, and pediatric primary care.
Limitations & Contraindications
Adult scoring thresholds and pharmacological formulas must never be applied to pediatric patients.
Clinical Pearls & Action Plan
Accurate weight-based dosing and age-stratified physiological vital sign reference ranges are foundational in pediatric clinical practice.
30 mg once daily, may titrate to 60 mg once daily (age >= 7 years)
Input Parameters
| Name | Type | Required | Description |
|---|---|---|---|
| weight_kg | float | Yes | Child's weight in kilograms(kg) |
| age_years | integer | Yes | Child's age in years(years) |
Score Interpretation & Guidance
| Range | Stage | Description |
|---|---|---|
| ≥ 0 | calculated | Weight-based dose |
Evidence-Based References (EBM)
- FDA Prescribing Information: Duloxetine (Cymbalta).